Cargando…

The association of tidal EFL with exercise performance, exacerbations, and death in COPD

BACKGROUND: Tidal expiratory flow limitation (EFL(T)) is frequently found in patients with COPD and can be detected by forced oscillations when within-breath reactance of a single-breath is ≥0.28 kPa·s·L(−1). The present study explored the association of within-breath reactance measured over multipl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aarli, Bernt Boegvald, Calverley, Peter MA, Jensen, Robert L, Dellacà, Raffaele, Eagan, Tomas ML, Bakke, Per S, Hardie, Jon A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536237/ https://www.ncbi.nlm.nih.gov/pubmed/28794622 http://dx.doi.org/10.2147/COPD.S138720

Ejemplares similares

Median regression spline modeling of longitudinal FEV(1) measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients
por: Conrad, Douglas J., et al.
Publicado: (2017)

Predictors of Exacerbations in Chronic Obstructive Pulmonary Disease - Results from the Bergen COPD Cohort Study
por: Husebø, Gunnar R., et al.
Publicado: (2014)

Lung hyperinflation and functional exercise capacity in patients with COPD – a three-year longitudinal study
por: Aalstad, Linn T., et al.
Publicado: (2018)

Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients
por: Erdal, Marta, et al.
Publicado: (2016)

The airway microbiota and exacerbations of COPD
por: Leiten, Elise Orvedal, et al.
Publicado: (2020)

Airway obstruction, dynamic hyperinflation, and breathing pattern during incremental exercise in COPD patients
por: Frisk, Bente, et al.
Publicado: (2014)

TNF-α is associated with loss of lean body mass only in already cachectic COPD patients
por: Eagan, Tomas ML, et al.
Publicado: (2012)

Peak oxygen uptake and breathing pattern in COPD patients – a four-year longitudinal study
por: Frisk, Bente, et al.
Publicado: (2015)

Vitamin D, Vitamin D Binding Protein, and Longitudinal Outcomes in COPD
por: Persson, Louise J. P., et al.
Publicado: (2015)

Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients
por: Tangedal, Solveig, et al.
Publicado: (2019)

Diffusion capacity and CT measures of emphysema and airway wall thickness – relation to arterial oxygen tension in COPD patients
por: Saure, Eirunn Waatevik, et al.
Publicado: (2016)

Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR(®) trial
por: Wise, Robert A, et al.
Publicado: (2018)

Guideline adherence in hospital recruited and population based COPD patients
por: Jouleh, Bahareh, et al.
Publicado: (2018)

Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients
por: Tangedal, Solveig, et al.
Publicado: (2014)

Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients
por: Tangedal, Solveig, et al.
Publicado: (2017)

Effect of nocturnal EPAP titration to abolish tidal expiratory flow limitation in COPD patients with chronic hypercapnia: a randomized, cross-over pilot study
por: Zannin, Emanuela, et al.
Publicado: (2020)

The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences
por: Grønseth, Rune, et al.
Publicado: (2014)

Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma
por: Gagnat, Ane Aamli, et al.
Publicado: (2020)

Chronic Obstructive Pulmonary Disease Is Associated with Low Levels of Vitamin D
por: Persson, Louise Jeanette Pauline, et al.
Publicado: (2012)

Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey
por: Voll-Aanerud, Marianne, et al.
Publicado: (2010)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

Predictors of diagnostic yield in bronchoscopy: a retrospective cohort study comparing different combinations of sampling techniques
por: Roth, Kjetil, et al.
Publicado: (2008)

COPD – do the right thing
por: Sandelowsky, Hanna, et al.
Publicado: (2021)

Overnight variation in tidal expiratory flow limitation in COPD patients and its correction: an observational study
por: McKenzie, J., et al.
Publicado: (2021)

Expert opinion of mediastinal lymph node positions from an intrabronchial view
por: Roth, Kjetil, et al.
Publicado: (2016)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
por: Calverley, Peter MA, et al.
Publicado: (2017)

Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients ‘on’ or ‘off’ augmentation therapy
por: Olfert, I Mark, et al.
Publicado: (2014)

Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD
por: Calverley, Peter MA, et al.
Publicado: (2018)

Factors associated with coronary heart disease in COPD patients and controls
por: Svendsen, Christina D., et al.
Publicado: (2022)

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

A score to predict short-term risk of COPD exacerbations (SCOPEX)
por: Make, Barry J, et al.
Publicado: (2015)

Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort
por: Le, Lan Ai Kieu, et al.
Publicado: (2019)

Chronic obstructive pulmonary disease and exacerbations: Patient insights from the global Hidden Depths of COPD survey
por: Barnes, Neil, et al.
Publicado: (2013)

Complications and discomfort after research bronchoscopy in the MicroCOPD study
por: Leiten, Elise Orvedal, et al.
Publicado: (2020)

Effect of different tidal volumes and PEEP levels on gas exchange and FRC
por: Chiumello, D, et al.
Publicado: (2000)

Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
por: Rennard, Stephen I, et al.
Publicado: (2011)

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
por: Eriksson, Göran, et al.
Publicado: (2017)

Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT
por: Putcha, Nirupama, et al.
Publicado: (2022)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dtjsd93iahljrnrikao486luo0